Scientific article

Impact de la vaccination sur les otites moyennes aiguës

Published inRevue médicale suisse, vol. 12, no. 506, p. 350-353
Publication date2016

Acute otitis media (AOM) is an important reason for medical visits and antibiotic use in children, with possible complications. Pneumococcal conjugate vaccines (PCV) have been developed from 2000, with first the apparition of the 7-valent PCV (PCV7), and from 2013, of the 13-valent PCV (PCV13). First developed to prevent invasive pneumococcal infections, they have been shown to reduce the number of AOM as well. PC13 has allowed to reduce the nasopharyngeal carriage of the majority of pneumococcal serotypes found in AOM, with a reduction of 77% of pneumococcal AOM, according to one study.

  • Acute Disease
  • Carrier State/epidemiology/prevention & control
  • Child
  • Humans
  • Nasopharynx/microbiology
  • Otitis Media/epidemiology/prevention & control
  • Pneumococcal Vaccines/therapeutic use
  • Vaccination/methods/statistics & numerical data
Citation (ISO format)
BLANCHARD ROHNER, Géraldine, GERVAIX, Alain. Impact de la vaccination sur les otites moyennes aiguës. In: Revue médicale suisse, 2016, vol. 12, n° 506, p. 350–353.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation10/20/2016 10:37:00 AM
First validation10/20/2016 10:37:00 AM
Update time03/15/2023 12:58:16 AM
Status update03/15/2023 12:58:15 AM
Last indexation01/16/2024 10:21:02 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack